Consentement d'utilisation des Cookies

J'accepte. Notre site sauvegarde des traceurs textes (cookies) sur votre appareil afin de vous garantir de meilleurs contenus et à des fins de collectes statistiques.Vous pouvez désactiver l'usage des cookies en changeant les paramètres de votre navigateur. En poursuivant votre navigation sur notre site sans changer vos paramètres de navigateur vous nous accordez la permission de conserver des informations sur votre appareil.

89-00-9 - Pyridine-2,3-dicarboxylic acid, 99% - Quinolinic acid - A11414 - Alfa Aesar

A11414 Pyridine-2,3-dicarboxylic acid, 99%

Numéro de CAS
89-00-9
Synonymes
Quinolinic acid

Conditionnement Prix ($) Quantité Disponibilité
25g 22,20
100g 57,40
Ajouter au panier Ajouter au devis en vrac Afficher l'article

Pyridine-2,3-dicarboxylic acid, 99%

MDL
MFCD00006295
EINECS
201-874-8

Propriétés chimiques

Formule
C7H5NO4
Poids moleculaire
167.12
Point de fusion
ca 188° dec.
Solubilité
Soluble in water (partly), alkalies, dilute aqueous base, DMSO, and alcohol (slightly).

Applications

Quinolinic acid is an endogenous NMDA agonist. Quinolinic acid is a metabolite of tryptophan that acts as a putative NMDA receptor agonist. Quinolinic acid is an “excitotoxic” metabolite and an agonist of N-methyl-D-aspartate receptors. properties of KYNA raise the possibility of a functional link between KYNA and QUIN in the brain which may be of relevance for an understanding of human neurodegenerative disorders. Quinolinic acid is a potent endogenous excitant at amino acid receptors in CNS.

Notes

Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Store away from strong oxidizing agents.

Références bibliographiques

MF Beal,; RJ Ferrante,; KJ Swartz,; NW Kowall. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. The Journal of Neuroscience,. 1991, 11(6), 1649-1659.

Dr Melvyn P. Heyes PhD,; Bruce J. Brew MD,; Alex Martin PhD,; Richard W. Price MD,; Andres M. Salazar MD.Quinolinic acid in cerebrospinal fluid and serum in HIV-1 Infection: Relationship to clinical and neurological status. Annals of Neurology. 1991 , 29 (2),202-209.

Mentions de danger et de prudence du SGH

Mentions de danger (UE): H315-H319-H335

Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.

Mentions de prudence: P261-P280a-P305+P351+P338-P304+P340-P405-P501a

Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves and eye/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Autres références

Merck
14,8073
Beilstein
137110
Code tarifaire harmonisé
2933.39
TSCA
Yes
RTECS
US7967250

Recommandé

  • A12124

    Diphenylphosphonic azide, 97%
  • A12683

    Nicotinic acid, 99%
  • A13285

    Formic acid, 97%
  • A14409

    Pyridine-2,4-dicarboxylic acid, 98%, may cont. up to ca 10% water
  • 33369

    Sodium hypochlorite, 11-15% available chlorine

Consulté récemment

Produits chimiques

Sciences de la vie

Métaux et matériaux

Catalyseurs

Analytique et matériel de laboratoire